Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients
Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muci...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d057b42a310240ed8e3bbeaf06f35107 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d057b42a310240ed8e3bbeaf06f35107 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d057b42a310240ed8e3bbeaf06f351072021-12-02T18:14:16ZAbiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients10.1038/s41467-020-18649-52041-1723https://doaj.org/article/d057b42a310240ed8e3bbeaf06f351072020-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-18649-5https://doaj.org/toc/2041-1723Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muciniphila at the expense of androgen-utilizing Corynebacterium species.Brendan A. DaisleyRyan M. ChanyiKamilah Abdur-RashidKait F. AlShaeley GibbonsJohn A. ChmielHannah WilcoxGregor ReidAmanda AndersonMalcolm DewarShiva M. NairJoseph ChinJeremy P. BurtonNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-11 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Brendan A. Daisley Ryan M. Chanyi Kamilah Abdur-Rashid Kait F. Al Shaeley Gibbons John A. Chmiel Hannah Wilcox Gregor Reid Amanda Anderson Malcolm Dewar Shiva M. Nair Joseph Chin Jeremy P. Burton Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients |
description |
Abiraterone acetate (AA) is indicated for the treatment of patients with metastatic castrate-resistant prostate cancer. Here, the authors show that, in prostate cancer patients, orally administered AA remodels the gut microbiome and promotes the enrichment of the commensal bacterium Akkermansia muciniphila at the expense of androgen-utilizing Corynebacterium species. |
format |
article |
author |
Brendan A. Daisley Ryan M. Chanyi Kamilah Abdur-Rashid Kait F. Al Shaeley Gibbons John A. Chmiel Hannah Wilcox Gregor Reid Amanda Anderson Malcolm Dewar Shiva M. Nair Joseph Chin Jeremy P. Burton |
author_facet |
Brendan A. Daisley Ryan M. Chanyi Kamilah Abdur-Rashid Kait F. Al Shaeley Gibbons John A. Chmiel Hannah Wilcox Gregor Reid Amanda Anderson Malcolm Dewar Shiva M. Nair Joseph Chin Jeremy P. Burton |
author_sort |
Brendan A. Daisley |
title |
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients |
title_short |
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients |
title_full |
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients |
title_fullStr |
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients |
title_full_unstemmed |
Abiraterone acetate preferentially enriches for the gut commensal Akkermansia muciniphila in castrate-resistant prostate cancer patients |
title_sort |
abiraterone acetate preferentially enriches for the gut commensal akkermansia muciniphila in castrate-resistant prostate cancer patients |
publisher |
Nature Portfolio |
publishDate |
2020 |
url |
https://doaj.org/article/d057b42a310240ed8e3bbeaf06f35107 |
work_keys_str_mv |
AT brendanadaisley abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT ryanmchanyi abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT kamilahabdurrashid abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT kaitfal abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT shaeleygibbons abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT johnachmiel abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT hannahwilcox abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT gregorreid abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT amandaanderson abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT malcolmdewar abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT shivamnair abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT josephchin abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients AT jeremypburton abirateroneacetatepreferentiallyenrichesforthegutcommensalakkermansiamuciniphilaincastrateresistantprostatecancerpatients |
_version_ |
1718378422549348352 |